NCT04505969

Brief Summary

This pilot research is aimed to assess the needs of patients and health workers involved in Sickle Cell Disease (SCD) management in Nigeria. To achieve this, a questionnaire will be administered to SCD patients or parents of children affected by SCD. Another questionnaire will be administered to doctors and nurses working with SCD patients. A focus group discussion with patients/parents willing to participate will be also scheduled. Participants from the following centres will be involved: Barau Dikko Teaching Hospital Kaduna State University, Ahmadu Bello University Teaching Hospital Zaria, National Hospital Abuja, Federal Medical Centre Katsina. Data will be qualitatively and quantitatively analysed and presented as aggregated data. Consent from all the study participants will be sought. Questionnaires will be coded and no personal data will be disclosed to authorised third parties.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
192

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2020

Shorter than P25 for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 6, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 10, 2020

Completed
1 day until next milestone

Study Start

First participant enrolled

August 11, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2020

Completed
3.5 years until next milestone

Results Posted

Study results publicly available

May 10, 2024

Completed
Last Updated

May 10, 2024

Status Verified

November 1, 2023

Enrollment Period

3 months

First QC Date

August 6, 2020

Results QC Date

September 20, 2022

Last Update Submit

November 23, 2023

Conditions

Keywords

Sickle Cell Diseasehealthcare professionals' needspatients'needsquestionnaires

Outcome Measures

Primary Outcomes (6)

  • Level of Satisfaction on SCD Current Treatment and Management

    Likert scale from 1 (very dissatisfied) to 5 (very satisfied). This Outcome Measure was pre-specified to be measured in only SCD patients/parents.

    Single-point assessment, at the enrolment

  • Rating of the Overall Service Quality

    Likert scale from 1 (very poor) to 5 (very good). This Outcome Measure was pre-specified to be measured in only SCD patients/parents.

    Single-point assessment, at the enrolment

  • Level of Satisfaction About Nursing Care in Clinic

    Likert scale from 1 (very dissatisfied) to 5 (very satisfied). This Outcome Measure was pre-specified to be measured in only SCD patients/parents.

    Single-point, at the enrollment

  • Rating of the Facilities to Manage SCD Patients

    Likert scale from 1 (very poor) to 5 (very good). This Outcome Measure was pre-specified to be measured in only healthcare professionals working with SCD patients

    Single-point assessment, at the enrolment

  • Level of Satisfaction on Responsibility

    Healthcare professionals have been asked to indicate their satisfaction about their responsibility in the clinic, using a Likert scale from 1 (very dissatisfied) to 5 (very satisfied). This Outcome Measure was pre-specified to be measured in only healthcare professionals working with SCD patients.

    Single-point assessment, at the enrolment

  • Level of Global Satisfaction on the Work With SCD Patients

    Likert scale from 1 (very dissatisfied) to 5 (very satisfied)

    Single-point assessment, at the enrolment

Secondary Outcomes (14)

  • Level of Appreciation of the Work

    Single-point assessment, at the enrolment

  • Level of Satisfaction on Protection From Injuries and Professional Risks

    Single-point assessment, at the enrolment

  • Level of Satisfaction on the Management of the Clinic

    Single-point assessment, at the enrolment

  • Level of Satisfaction on the Instruction Given by Doctor About Pain Control

    Single-point assessment, at the enrollment

  • Level of Satisfaction on the Support Received at the Time of the Diagnosis

    Single-point assessment, at the enrolment

  • +9 more secondary outcomes

Study Arms (2)

SCD patients

Other: Questionnaire to assess needs

Healthcare professionals

Other: Questionnaire to assess needs

Interventions

Two questionnaires have been developed to assess the specific needs of healthcare professionals working with SCD patients and of SCD patients or parents of children with SCD

Healthcare professionalsSCD patients

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with a diagnosis of Sickle Cell Disease or parents having a child with a diagnosis of Sickle Cell Disease attending one of the clinical centres involved in the study. Healthcare professionals, e.g. doctors, nurses, working with Sickle Cell Disease patients in the clinical centres involved in the study.

You may qualify if:

  • Aged ≥ 18
  • Have SCD diagnosis or having a child with a SCD diagnosis
  • Attending the centre from at least 6 months
  • Nigerian nationality
  • Informed Consent signed
  • Working in a SCD clinic
  • At least 5 years of experience with SCD patients
  • Informed Consent signed

You may not qualify if:

  • Informed consent form withdrawal
  • Illiterate subjects
  • Any psychiatric conditions impairing the participation in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

National Hospital Abuja

Abuja, Nigeria

Location

Barau Dikko Teaching Hospital, Kaduna State University

Kaduna, Nigeria

Location

Federal Medical Centre Katsina

Katsina, Nigeria

Location

Ahmadu Bello University Teaching Hospital Zaria

Zaria, Nigeria

Location

Related Publications (8)

  • Adewoyin AS. Management of sickle cell disease: a review for physician education in Nigeria (sub-saharan Africa). Anemia. 2015;2015:791498. doi: 10.1155/2015/791498. Epub 2015 Jan 18.

    PMID: 25667774BACKGROUND
  • Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med. 2011 Dec;41(6 Suppl 4):S398-405. doi: 10.1016/j.amepre.2011.09.013.

    PMID: 22099364BACKGROUND
  • King L, Knight-Madden J, Reid M. Newborn screening for sickle cell disease in Jamaica: a review - past, present and future. West Indian Med J. 2014 Mar;63(2):147-50. doi: 10.7727/wimj.2013.107. Epub 2014 Apr 11.

    PMID: 25303249BACKGROUND
  • Galadanci N, Wudil BJ, Balogun TM, Ogunrinde GO, Akinsulie A, Hasan-Hanga F, Mohammed AS, Kehinde MO, Olaniyi JA, Diaku-Akinwumi IN, Brown BJ, Adeleke S, Nnodu OE, Emodi I, Ahmed S, Osegbue AO, Akinola N, Opara HI, Adegoke SA, Aneke J, Adekile AD. Current sickle cell disease management practices in Nigeria. Int Health. 2014 Mar;6(1):23-8. doi: 10.1093/inthealth/iht022. Epub 2013 Oct 10.

    PMID: 24114193BACKGROUND
  • Green NS, Mathur S, Kiguli S, Makani J, Fashakin V, LaRussa P, Lyimo M, Abrams EJ, Mulumba L, Mupere E. Family, Community, and Health System Considerations for Reducing the Burden of Pediatric Sickle Cell Disease in Uganda Through Newborn Screening. Glob Pediatr Health. 2016 Apr 7;3:2333794X16637767. doi: 10.1177/2333794X16637767. eCollection 2016.

    PMID: 27336011BACKGROUND
  • Makani J, Soka D, Rwezaula S, Krag M, Mghamba J, Ramaiya K, Cox SE, Grosse SD. Health policy for sickle cell disease in Africa: experience from Tanzania on interventions to reduce under-five mortality. Trop Med Int Health. 2015 Feb;20(2):184-7. doi: 10.1111/tmi.12428. Epub 2014 Nov 17.

    PMID: 25365928BACKGROUND
  • McGann PT, Grosse SD, Santos B, de Oliveira V, Bernardino L, Kassebaum NJ, Ware RE, Airewele GE. A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of Angola. J Pediatr. 2015 Dec;167(6):1314-9. doi: 10.1016/j.jpeds.2015.08.068. Epub 2015 Oct 23.

    PMID: 26477868BACKGROUND
  • World Health Organization. Sickle-Cell Anaemia Report by the Secretariat. Fifty-Ninth World Health Assembly, c2006. Available from: http://www. apps.who.int/gb/ebwha/pdf_files/WHA59/A59_9-en.pdf

    BACKGROUND

MeSH Terms

Conditions

Anemia, Sickle Cell

Condition Hierarchy (Ancestors)

Anemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHematologic DiseasesHemic and Lymphatic DiseasesHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Limitations and Caveats

Challenges due to the COVID-19 pandemics impacted on the conduction of the study. Recruitment target was lower than expectations, timelines were extended and the protocol was amended.

Results Point of Contact

Title
Study Principal investigator
Organization
Barau Dikko Teaching Hospital, Kaduna State University

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 6, 2020

First Posted

August 10, 2020

Study Start

August 11, 2020

Primary Completion

November 11, 2020

Study Completion

November 11, 2020

Last Updated

May 10, 2024

Results First Posted

May 10, 2024

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will share

The research data needed to validate the results presented in the published scientific papers will be made available for verification and re-use, unless there will arise justified reasons for keeping specific datasets confidential. This will be done in compliance with the obligation to protect results, the confidentiality obligations, the security obligations, and the obligations to protect personal data as set out in the ARISE Partnership Agreement and in the Study Protocol. All the data will be anonymised before publishing.

Time Frame
Data will be made available for verification at the time of study results publication in a peer-reviewed journal
Access Criteria
A controlled access to research data will be sought. A data access form will be made available, asking for: the purpose for data request, applicant information, brief description of the research project, description of requested data, any plan for publishing results. According to the type of data, the terms for sharing will be evaluated.

Locations